264 related articles for article (PubMed ID: 9973194)
1. Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins.
Dotzlaw H; Leygue E; Watson PH; Murphy LC
Cancer Res; 1999 Feb; 59(3):529-32. PubMed ID: 9973194
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
[TBL] [Abstract][Full Text] [Related]
5. Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.
Simon SL; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson PH; Murphy LC
Cancer Res; 2000 Jun; 60(11):2796-9. PubMed ID: 10850416
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
8. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Cancer Res; 1998 Aug; 58(15):3197-201. PubMed ID: 9699641
[TBL] [Abstract][Full Text] [Related]
9. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.
Dotzlaw H; Leygue E; Watson P; Murphy LC
Clin Cancer Res; 1999 Aug; 5(8):2103-7. PubMed ID: 10473093
[TBL] [Abstract][Full Text] [Related]
10. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
Dotzlaw H; Miller T; Karvelas J; Murphy LC
Cancer Res; 1990 Jul; 50(14):4204-8. PubMed ID: 2364377
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
Kim HJ; Cui X; Hilsenbeck SG; Lee AV
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?
Speirs V; Parkes AT; Kerin MJ; Walton DS; Carleton PJ; Fox JN; Atkin SL
Cancer Res; 1999 Feb; 59(3):525-8. PubMed ID: 9973193
[TBL] [Abstract][Full Text] [Related]
17. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed genes and estrogen receptor status in breast cancer.
Nagai MA; Ros N; Bessa SA; Mourão Neto M; Miracca EC; Brentani MM
Int J Oncol; 2003 Nov; 23(5):1425-30. PubMed ID: 14532986
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]